Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission

N Larbalestier(Guy's Hospital), Annemiek de Ruiter(ViiV Healthcare (Spain)), Graham P. Taylor(NIHR Imperial Biomedical Research Centre), Fiona Cottam(St Thomas' Hospital), Mark Zuckerman, Caroline Sabin(Primary Health Care), Phillip Hay(Northwick Park Hospital), Jan Welch(King's College - North Carolina), I. L. Chrystie(St Thomas' Hospital), Jane Mullen(St Thomas' Hospital), Phillip Rice(St George's Hospital), Siobhan O’Shea(St Thomas' Hospital)
AIDS
November 13, 2003
10.1097/00002030-200312050-00015
Cited by 25

Related Papers

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
Targeting C-reactive protein for the treatment of cardiovascular disease
|Nature|2006|676
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
|The Journal of Infectious Diseases|2009|649
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631